{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreieddz6pc3kskaz5jmfyqq2x4jnogb2ilxmi64g7zx27evkxbjopq4",
    "uri": "at://did:plc:y3rk3ke54ib6rnpokcmyihba/app.bsky.feed.post/3mldb7pj7ctc2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreidvexhzwthqggdr37dk5zgcczwbuxd23t7coxcpl2fly5l7ksnm2m"
    },
    "mimeType": "image/jpeg",
    "size": 224798
  },
  "path": "/article/news/health/beyond-ozempic-how-glp-1-drugs-are-changing-the-conversation-around-weight-loss-bariatric-surgeon-promedica/512-1c1a957b-5aaa-4309-b31a-afa37c3a58f5",
  "publishedAt": "2026-05-08T03:05:14.000Z",
  "site": "https://www.wtol.com",
  "tags": [
    "health",
    "news",
    "local",
    "home"
  ],
  "textContent": "Drugs like Ozempic and Zepbound are changing weight loss and health care. But doctors say there’s still a lot to be learned.",
  "title": "Beyond Ozempic: How GLP-1 drugs are changing the conversation around weight loss"
}